Cancer Gene Therapy

Gene Gun Tested in Cancer Patients

Published in Gene Therapy Weekly, November 4th, 1996

A cancer vaccine has passed laboratory scrutiny and is being tested in patients at the University of Wisconsin Comprehensive Cancer Center (UWCCC).

The pilot study, believed to be the first use of gene therapy in Wisconsin and the first test of "gene gun" technology in cancer patients, attempts to produce an immune response powerful enough to stop tumor growth in patients, according to Dr. David Mahvi, UWCCC.

By evaluating the safety and practicality of the approach in patients with aggressive cancers - melanoma and soft tissue sarcomas, researchers hope to find a better way to treat tumors that are hard to stop and tend to return, Mahvi said.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1996-11-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry